Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the launch of EDEN, a large, multi-center prospective study designed to evaluate the company’s non ...

MedGenome unveils MetaSeq, a groundbreaking blood test capable of detecting over 1,400 pathogens in just five days, enhancing ...

A low DNA binding consumables range minimizes interactions between nucleic acids and plastic surfaces, supporting more ...

Scientists reverse eye cell aging with ER-100 gene therapy that reprograms retinal neurons to younger states, offering hope ...

Ginkgo Bioworks says a new AI collaboration with OpenAI is already paying off, cutting the cost of protein production in the lab by a mea ...

It had been thought that AI would play a big part in digital-only domains like math and coding, but cleverly connecting these ...

The Pima County Sheriff’s Office says it is actively pursuing hundreds of leads in the disappearance of 84-year-old Nancy ...

A study reveals that omega-3 can slow down DNA aging, pointing to a minimal formula against the passage of time.

In A Nutshell Johns Hopkins researchers developed a blood test that catches 81% of stage IA lung cancers (the earliest, most ...

Galleri is a multi-cancer early detection (MCED) or 'liquid biopsy' test that Grail says can spot signs of up to 50 different ...

MedGenome expands its infectious disease testing portfolio with MetaSeq, a single test that detects over 1,400 pathogens: Our Bureau, Bengaluru Thursday, February 5, 2026, 14:15 H ...

Natera submits premarket approval to US FDA for Signatera CDx for detection of MRD in patients with muscle-invasive bladder cancer: Austin, Texas Wednesday, February 4, 2026, 18:0 ...